148 related articles for article (PubMed ID: 2006015)
1. Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.
Peynet J; Laurent A; De Liege P; Lecoz P; Gambert P; Legrand A; Mikol J; Warnet A
Neurology; 1991 Mar; 41(3):434-6. PubMed ID: 2006015
[TBL] [Abstract][Full Text] [Related]
2. Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy.
Watts GF; Mitchell WD; Bending JJ; Reshef A; Leitersdorf E
QJM; 1996 Jan; 89(1):55-63. PubMed ID: 8730343
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
Chang WN; Kuriyama M; Chee EC
J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S
Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of familial cerebrotendinous xanthomatosis--intrahepatic enzyme assay and therapeutic trial with chenodeoxycholic acid].
Orimo S; Kobayashi T; Furukawa T; Tsukagoshi H; Kano I
Rinsho Shinkeigaku; 1984 Jan; 24(1):38-44. PubMed ID: 6467736
[No Abstract] [Full Text] [Related]
7. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
Kuriyama M; Tokimura Y; Fujiyama J; Utatsu Y; Osame M
J Neurol Sci; 1994 Aug; 125(1):22-8. PubMed ID: 7964884
[TBL] [Abstract][Full Text] [Related]
8. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Batta AK; Salen G; Tint GS
Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cerebrotendinous xanthomatosis.
Federico A; Dotti MT
Neurology; 1994 Nov; 44(11):2218. PubMed ID: 7970001
[No Abstract] [Full Text] [Related]
11. Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis.
Lewis B; Mitchell WD; Marenah CB; Cortese C; Reynolds EH; Shakir R
Br Med J (Clin Res Ed); 1983 Jul; 287(6384):21-2. PubMed ID: 6407679
[No Abstract] [Full Text] [Related]
12. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
[TBL] [Abstract][Full Text] [Related]
13. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
Tint GS; Ginsberg H; Salen G; Le NA; Shefer S
J Lipid Res; 1989 May; 30(5):633-40. PubMed ID: 2760539
[TBL] [Abstract][Full Text] [Related]
14. [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
Kondo R; Wakamatsu N; Ishikawa A; Yuasa T; Miyatake T
Rinsho Shinkeigaku; 1991 Jun; 31(6):677-9. PubMed ID: 1934787
[TBL] [Abstract][Full Text] [Related]
15. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.
Donaghy M; King RH; McKeran RO; Schwartz MS; Thomas PK
J Neurol; 1990 Jun; 237(3):216-9. PubMed ID: 2196342
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
Berginer VM; Salen G; Shefer S
N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
[TBL] [Abstract][Full Text] [Related]
18. [Cerebrotendinous xanthomatosis].
Berginer VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
[TBL] [Abstract][Full Text] [Related]
19. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.
Verrips A; Wevers RA; Van Engelen BG; Keyser A; Wolthers BG; Barkhof F; Stalenhoef A; De Graaf R; Janssen-Zijlstra F; Van Spreeken A; Gabreëls FJ
Metabolism; 1999 Feb; 48(2):233-8. PubMed ID: 10024088
[TBL] [Abstract][Full Text] [Related]
20. Cerebrotendinous xanthomatosis is treatable.
White SW
Pediatr Dermatol; 1985 Jul; 2(4):294-6. PubMed ID: 3925446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
